3.11
Schlusskurs vom Vortag:
$3.06
Offen:
$3.02
24-Stunden-Volumen:
20,263
Relative Volume:
0.01
Marktkapitalisierung:
$11.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$1.52M
KGV:
-0.492
EPS:
-6.3213
Netto-Cashflow:
$-1.14M
1W Leistung:
+1.63%
1M Leistung:
-11.40%
6M Leistung:
-37.02%
1J Leistung:
-89.85%
Psyence Biomedical Ltd Stock (PBM) Company Profile
Firmenname
Psyence Biomedical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare PBM vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PBM
Psyence Biomedical Ltd
|
3.11 | 11.67M | 0 | 1.52M | -1.14M | -6.3213 |
|
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Psyence Biomedical Ltd Aktie (PBM) Neueste Nachrichten
PBMPsyence Biomedical Ltd Earnings - Finviz
Tranche Update on Psyence Biomedical Ltd.'s Equity Buyback Plan announced on January 12, 2026. - marketscreener.com
PBM Stock On Track For Best Session On Report Of Upcoming Trump Executive Order On Psychedelic Ibogaine - Stocktwits
Psyence Biomedical Ltd (PBM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
$Psyence Biomedical (PBM.US)$ - Moomoo
Psyence Biomedical (Nasdaq: PBM) outlines losses, cash runway and trial risks in 20-F - Stock Titan
Psyence Biomedical Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Nasdaq, S&P 500 Futures Fall, Oil Risk Back In Focus After Trump’s Iran Escalation: Why PBM, FRMI, ASTS, BATL Are Keeping Traders Engaged Today - Stocktwits
Psyence Biomedical Ltd (PBM) Valuation: PE, PB & Fair Value Analysis - TradingKey
PBMWW | Psyence Biomedical Ltd. Warrant Insider Trading - Quiver Quantitative
Psyence Biomedical Ltd (PBM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Psyence Biomedical Ltd (PBM) Institutional Confidence - TradingKey
Psyence Biomedical Ltd (PBM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Psyence Biomedical Ltd (PBM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Psyence Biomedical Ltd (PBMWW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Psyence Biomedical Ltd (PBMWW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Psyence Biomedical Ltd (PBMWW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Psyence Biomedical Ltd (PBM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Psyence Biomedical Ltd (PBM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Psyence Biomedical Ltd (PBMWW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Psyence Biomedical Ltd (PBM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Psyence Biomedical Ltd (PBMWW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Psyence Biomedical Ltd (PBMWW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Psyence Biomedical Ltd (PBMWW) Institutional Confidence - TradingKey
Psyence Biomedical Ltd (PBMWW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Psyence Biomedical Ltd (PBMWW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PBM News | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
PBMWW Warrants Slide 9.25% as Psyence Biomedical Faces Continued Selling PressureGamma Exposure - newsline.com
Jeffrey Weiner holds 59,750 shares in PSYENCE BIOMEDICAL LTD. (PBM) - Stock Titan
Psyence Biomedical Company Profile & Introduction - Moomoo
Psyence Biomedical Corrects Technical Error in 2023 Equity Incentive Plan - TipRanks
Psyence Biomedical (PBM) corrects error in 2023 equity incentive plan - Stock Titan
Psyence Biomedical draws attention premarket after filing on 30% stake - Bez Kabli
Psyence Biomedical (PBM) Surges Over 7%: Bullish Momentum Builds Near ResistanceEnding Diagonal - newsline.com
Psyence Labs Discloses Investment in PSYENCE BIOMEDICAL LTD. with 30.05% Stake - TradingView
Psyence Labs gains 30.05% ownership of Psyence Biomedical (PBM) - Stock Titan
Psyence Biomedical Ltd. Warrant (PBMWW) Slides 8.94% as Stock Hovers at $0.03Market Cap Weight - The Legal Advocate
Psyence Biomedical (PBM) Rallies 5.85% as Shares Test Key Resistance Near $4.56Value Area High - The Legal Advocate
Psyence Biomedical Ltd. (PBM) Edges Higher Amid Sector Rotation and Key Technical LevelsUpthrust Pattern - The Legal Advocate
Psyence Biomedical Warrants (PBMWW) Edge Higher; Support and Resistance Converge at $0.03Momentum Breakout Ideas - The Legal Advocate
$Psyence Biomedical (PBM.US)$ picked me up lets goooo - Moomoo
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing - marketscreener.com
Psyence BioMed Announces U.S. Strategic Engagement - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
PBM Stock Chart | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
TradingKey - TradingKey
Finanzdaten der Psyence Biomedical Ltd-Aktie (PBM)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):